Daiichi Sankyo
- All
- News
- Videos
-
Enhertu Sharply Improves Survival In Breast Cancer Patients: Report
A drug from AstraZeneca Plc and Daiichi Sankyo Co. extended the lives of patients with an advanced form of breast cancer by about six months in a late-stage trial that may widen the population of people who can benefit from the treatment.
-
Singh Brothers, Ex-Ranbaxy Promoters, Guilty Of Contempt: Supreme Court
Ex-Ranbaxy promoters Malvinder Singh and his brother Shivinder Singh have been held guilty by the Supreme Court of contempt of court in a case filed by Japanese firm Daiichi Sankyo.
-
Daiichi Sankyo Case: Supreme Court Reserves Order On Plea Against Singh Brothers
The bench headed by Chief Justice Ranjan Gogoi said it will decide on the issue of "contempt of court" only.
-
"Will Send You To Jail," Ranbaxy Singh Brothers Told By Court: 10 Points
The former promoters of pharmaceutical company Ranbaxy, Malvinder Mohan Singh and his brother Shivinder Mohan Singh, were told by the Supreme Court today that they could go to jail for disobeying orders to pay dues to Japanese firm Daiichi Sankyo. "We will go into the issue - why you violated our orders. We will send you to jail. We have given you ...
-
"Renouncing World Good For You, Not Us," Supreme Court Tells Ranbaxy Ex-Promoters
The Supreme Court today asked former Fortis Healthcare promoters and estranged brothers Malvinder Singh and Shivinder Singh to inform it on how they plan to comply with a Rs 3,500 crore arbitration order passed against them by a Singapore tribunal. "You were the flag bearers of the pharmacare industry and it doesn't look good that you are appearing...
-
Supreme Court Orders Malvinder, Shivinder Singh To Appear On March 14
The court ordered the presence of two brothers on a plea by the Japanese drug maker Daiichi Sankyo.
-
Why Is Fortis Buying Back Its Assets Less Than 7 Years After Divesting?
RHT Health Trust, which was originally named Religare Health Trust, netted Fortis about 510 million Singapore dollars when it listed in October 2012.
-
"Decision To Part Ways With Brother Stands," Says Fortis' Shivinder Singh
Fortis co-founder Shivinder Mohan Singh said on Friday that his request to withdraw the plea that he filed against his older brother Malvinder Mohan Singh was on Friday accepted by the court but also made it clear that his decision to end business ties with his sibling stands. "The honourable NCLT today granted my request to withdraw the petition o...
-
Fortis Co-Founder Shivinder Singh Sues Elder Brother For "Mismanagement"
Billionaire Shivinder Mohan Singh, co-founder of hospital chain Fortis Healthcare and former Ranbaxy promoter, has filed a case against his elder brother Malvinder Mohan Singh alleging "oppression and mismanagement" at their joint businesses - RHC Holding, Religare and Fortis.
-
Daiichi Sankyo Asks ED To Probe Singh Brothers' Transactions: A Timeline
Singh brothers lost the case in Singapore arbitration court that ordered them to pay Rs 3,500 crore to Daiichi Sankyo.
-
Lupin Gets US Regulator's Nod For Hypertension Treatment Drug In US
Olmesartan Medoximil tablets, a generic version of Daiichi Sankyo's Benicar, are indicated for the treatment of hypertension, along with other anti-hypertensive agents to lower blood pressure, it added.
-
Sun Pharma Launches Blood Pressure Drugs In US
Sun Pharmaceutical Industries today said it has launched generic versions of Daiichi Sankyo medicines, used in treatment of high blood pressure, in the US market.
-
Sun Pharma Shares Jump On Taro's Q4
Sun Pharmaceuticals shares jumped over 5 per cent on Friday after the drugmaker's US-based subsidiary Taro Pharma reported strong earnings.
-
Sun Pharma, Daiichi Terminate Transaction Pacts
Sun Pharmaceutical Industries on Thursday said the umbrella pact and transaction agreements signed with Daiichi Sankyo and its overseas subsidiaries have been terminated due to divestment of Ranbaxy by the Japanese firm.
-
Former Ranbaxy Promoters Fined: Fortis Healthcare, Religare Fall
Fortis Healthcare shares fell nearly 5 per cent on Friday, while Religare Enterprises shares traded 1 per cent lower. Both Fortis and Religare shares were headed for a fourth straight day of losses.
-
Enhertu Sharply Improves Survival In Breast Cancer Patients: Report
A drug from AstraZeneca Plc and Daiichi Sankyo Co. extended the lives of patients with an advanced form of breast cancer by about six months in a late-stage trial that may widen the population of people who can benefit from the treatment.
-
Singh Brothers, Ex-Ranbaxy Promoters, Guilty Of Contempt: Supreme Court
Ex-Ranbaxy promoters Malvinder Singh and his brother Shivinder Singh have been held guilty by the Supreme Court of contempt of court in a case filed by Japanese firm Daiichi Sankyo.
-
Daiichi Sankyo Case: Supreme Court Reserves Order On Plea Against Singh Brothers
The bench headed by Chief Justice Ranjan Gogoi said it will decide on the issue of "contempt of court" only.
-
"Will Send You To Jail," Ranbaxy Singh Brothers Told By Court: 10 Points
The former promoters of pharmaceutical company Ranbaxy, Malvinder Mohan Singh and his brother Shivinder Mohan Singh, were told by the Supreme Court today that they could go to jail for disobeying orders to pay dues to Japanese firm Daiichi Sankyo. "We will go into the issue - why you violated our orders. We will send you to jail. We have given you ...
-
"Renouncing World Good For You, Not Us," Supreme Court Tells Ranbaxy Ex-Promoters
The Supreme Court today asked former Fortis Healthcare promoters and estranged brothers Malvinder Singh and Shivinder Singh to inform it on how they plan to comply with a Rs 3,500 crore arbitration order passed against them by a Singapore tribunal. "You were the flag bearers of the pharmacare industry and it doesn't look good that you are appearing...
-
Supreme Court Orders Malvinder, Shivinder Singh To Appear On March 14
The court ordered the presence of two brothers on a plea by the Japanese drug maker Daiichi Sankyo.
-
Why Is Fortis Buying Back Its Assets Less Than 7 Years After Divesting?
RHT Health Trust, which was originally named Religare Health Trust, netted Fortis about 510 million Singapore dollars when it listed in October 2012.
-
"Decision To Part Ways With Brother Stands," Says Fortis' Shivinder Singh
Fortis co-founder Shivinder Mohan Singh said on Friday that his request to withdraw the plea that he filed against his older brother Malvinder Mohan Singh was on Friday accepted by the court but also made it clear that his decision to end business ties with his sibling stands. "The honourable NCLT today granted my request to withdraw the petition o...
-
Fortis Co-Founder Shivinder Singh Sues Elder Brother For "Mismanagement"
Billionaire Shivinder Mohan Singh, co-founder of hospital chain Fortis Healthcare and former Ranbaxy promoter, has filed a case against his elder brother Malvinder Mohan Singh alleging "oppression and mismanagement" at their joint businesses - RHC Holding, Religare and Fortis.
-
Daiichi Sankyo Asks ED To Probe Singh Brothers' Transactions: A Timeline
Singh brothers lost the case in Singapore arbitration court that ordered them to pay Rs 3,500 crore to Daiichi Sankyo.
-
Lupin Gets US Regulator's Nod For Hypertension Treatment Drug In US
Olmesartan Medoximil tablets, a generic version of Daiichi Sankyo's Benicar, are indicated for the treatment of hypertension, along with other anti-hypertensive agents to lower blood pressure, it added.
-
Sun Pharma Launches Blood Pressure Drugs In US
Sun Pharmaceutical Industries today said it has launched generic versions of Daiichi Sankyo medicines, used in treatment of high blood pressure, in the US market.
-
Sun Pharma Shares Jump On Taro's Q4
Sun Pharmaceuticals shares jumped over 5 per cent on Friday after the drugmaker's US-based subsidiary Taro Pharma reported strong earnings.
-
Sun Pharma, Daiichi Terminate Transaction Pacts
Sun Pharmaceutical Industries on Thursday said the umbrella pact and transaction agreements signed with Daiichi Sankyo and its overseas subsidiaries have been terminated due to divestment of Ranbaxy by the Japanese firm.
-
Former Ranbaxy Promoters Fined: Fortis Healthcare, Religare Fall
Fortis Healthcare shares fell nearly 5 per cent on Friday, while Religare Enterprises shares traded 1 per cent lower. Both Fortis and Religare shares were headed for a fourth straight day of losses.
